219 related articles for article (PubMed ID: 34666750)
21. Budesonide enhances agonist-induced bronchodilation in human small airways by increasing cAMP production in airway smooth muscle.
Koziol-White C; Johnstone TB; Corpuz ML; Cao G; Orfanos S; Parikh V; Deeney B; Tliba O; Ostrom RS; Dainty I; Panettieri RA
Am J Physiol Lung Cell Mol Physiol; 2020 Feb; 318(2):L345-L355. PubMed ID: 31747297
[TBL] [Abstract][Full Text] [Related]
22. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation.
Konrad FM; Bury A; Schick MA; Ngamsri KC; Reutershan J
PLoS One; 2015; 10(4):e0121725. PubMed ID: 25909327
[TBL] [Abstract][Full Text] [Related]
23. β2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids.
Holden NS; Bell MJ; Rider CF; King EM; Gaunt DD; Leigh R; Johnson M; Siderovski DP; Heximer SP; Giembycz MA; Newton R
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19713-8. PubMed ID: 22080612
[TBL] [Abstract][Full Text] [Related]
24. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid Receptor α Mediates Roflumilast's Ability to Restore Dexamethasone Sensitivity in COPD.
Reddy AT; Lakshmi SP; Banno A; Reddy RC
Int J Chron Obstruct Pulmon Dis; 2020; 15():125-134. PubMed ID: 32021151
[TBL] [Abstract][Full Text] [Related]
26. Roflumilast N-Oxide in Combination with Formoterol Enhances the Antiinflammatory Effect of Dexamethasone in Airway Smooth Muscle Cells.
Patel BS; Rahman MM; Baehring G; Xenaki D; Tang FS; Oliver BG; Ammit AJ
Am J Respir Cell Mol Biol; 2017 Apr; 56(4):532-538. PubMed ID: 27997807
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication.
Marcellini A; Swieboda D; Guedán A; Farrow SN; Casolari P; Contoli M; Johnston SL; Papi A; Solari R
Eur J Pharmacol; 2021 Feb; 893():173839. PubMed ID: 33359650
[TBL] [Abstract][Full Text] [Related]
28. Additive anti-inflammatory effects of beta 2 adrenoceptor agonists or glucocorticosteroid with roflumilast in human peripheral blood mononuclear cells.
Tannheimer SL; Sorensen EA; Haran AC; Mansfield CN; Wright CD; Salmon M
Pulm Pharmacol Ther; 2012 Apr; 25(2):178-84. PubMed ID: 22306235
[TBL] [Abstract][Full Text] [Related]
29. Long acting β2-agonist's activation of cyclic AMP cannot halt ongoing mitogenic stimulation in airway smooth muscle cells.
Qi Y; Fang L; Stolz D; Tamm M; Roth M
Pulm Pharmacol Ther; 2019 Jun; 56():20-28. PubMed ID: 30876906
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of phosphodiesterase 4 modulates cytokine induction from toll like receptor activated, but not rhinovirus infected, primary human airway smooth muscle.
Van Ly D; De Pedro M; James P; Morgan L; Black JL; Burgess JK; Oliver BG
Respir Res; 2013 Nov; 14(1):127. PubMed ID: 24237854
[TBL] [Abstract][Full Text] [Related]
31. Cigarette smoke up-regulates PDE3 and PDE4 to decrease cAMP in airway cells.
Zuo H; Han B; Poppinga WJ; Ringnalda L; Kistemaker LEM; Halayko AJ; Gosens R; Nikolaev VO; Schmidt M
Br J Pharmacol; 2018 Jul; 175(14):2988-3006. PubMed ID: 29722436
[TBL] [Abstract][Full Text] [Related]
32. β2-Agonist induced cAMP is decreased in asthmatic airway smooth muscle due to increased PDE4D.
Trian T; Burgess JK; Niimi K; Moir LM; Ge Q; Berger P; Liggett SB; Black JL; Oliver BG
PLoS One; 2011; 6(5):e20000. PubMed ID: 21611147
[TBL] [Abstract][Full Text] [Related]
33. Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands.
Rider CF; Shah S; Miller-Larsson A; Giembycz MA; Newton R
PLoS One; 2015; 10(1):e0116773. PubMed ID: 25625944
[TBL] [Abstract][Full Text] [Related]
34. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
35. Phosphodiesterase 4 mediates interleukin-8-induced heterologous desensitization of the β
Rich TC; Leavesley SJ; Brandon AP; Evans CA; Raju SV; Wagener BM
FASEB J; 2021 Oct; 35(10):e21946. PubMed ID: 34555226
[TBL] [Abstract][Full Text] [Related]
36. Modulation of transcriptional responses by poly(I:C) and human rhinovirus: effect of long-acting β₂-adrenoceptor agonists.
Rider CF; Miller-Larsson A; Proud D; Giembycz MA; Newton R
Eur J Pharmacol; 2013 May; 708(1-3):60-7. PubMed ID: 23523474
[TBL] [Abstract][Full Text] [Related]
37. NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues.
Yougbare I; Morin C; Senouvo FY; Sirois C; Albadine R; Lugnier C; Rousseau E
Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L441-50. PubMed ID: 21784969
[TBL] [Abstract][Full Text] [Related]
38. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
39. Oxidative stress-induced glucocorticoid resistance is prevented by dual PDE3/PDE4 inhibition in human alveolar macrophages.
Milara J; Navarro A; Almudéver P; Lluch J; Morcillo EJ; Cortijo J
Clin Exp Allergy; 2011 Apr; 41(4):535-46. PubMed ID: 21395877
[TBL] [Abstract][Full Text] [Related]
40. PGE 2 desensitizes β -agonist effect on human lung fibroblast-mediated collagen gel contraction through upregulating PDE4.
Fang Q; Ma Y; Wang J; Michalski J; Rennard SI; Liu X
Mediators Inflamm; 2013; 2013():145197. PubMed ID: 24227907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]